Results 171 to 180 of about 17,590 (203)

Stable Triple Cation Perovskite Precursor for Highly Efficient Perovskite Solar Cells Enabled by Interaction with 18C6 Stabilizer

Advanced Functional Materials, 2020
Guofu Zhou, Jinwei Gao, Jun-ming Liu
exaly  

Perovskite precursor solution chemistry: from fundamentals to photovoltaic applications

Chemical Society Reviews, 2019
Minsu Jung, Gwisu Kim, Sang Il Seok
exaly  

Fused‐Ring Electron Acceptor ITIC‐Th: A Novel Stabilizer for Halide Perovskite Precursor Solution

Advanced Energy Materials, 2018
Jianbin Xu, Jianbin Xu, Jiayu Wang
exaly  

Stabilization of Precursor Solution and Perovskite Layer by Addition of Sulfur

Advanced Energy Materials, 2019
Gwisu Kim, Hanul Min, Minsu Jung
exaly  

Highly Efficient Sn/Pb Binary Perovskite Solar Cell via Precursor Engineering: A Two‐Step Fabrication Process

Advanced Functional Materials, 2019
Gang Wu, Hongzheng Chen, Minchao Qin
exaly  

The Interleukin-1α Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of Cytokines

Frontiers in Immunology, 2013
Soyoon Ryoo, Soohyun Kim
exaly  

Engineering Halide Perovskite Crystals through Precursor Chemistry

Small, 2019
Bo Li, David J Binks, Guozhong Cao
exaly  

Human medicines European public assessment report (EPAR): Imatinib Accord, imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma,Dermatofibrosarcoma,Myelodysplastic-Myeloproliferative Diseases,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Hypereosinophilic Syndrome, Date of authorisation: 30/06/2013, Revision: 15, Status: Authorised

, 2018

openalex   +1 more source

A Protocol for Isolation and Enriched Monolayer Cultivation of Neural Precursor Cells from Mouse Dentate Gyrus

Frontiers in Neuroscience, 2011
Suresh Kannan, Gerd Kempermann, Johan Lundberg   +2 more
exaly  

Human medicines European public assessment report (EPAR): Glivec, imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma,Gastrointestinal Stromal Tumors,Dermatofibrosarcoma,Myelodysplastic-Myeloproliferative Diseases,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Hypereosinophilic Syndrome, Date of authorisation: 07/11/2001, Revision: 34, Status: Authorised

, 2019

openalex   +1 more source